Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Tenet Healthcare Corp (THC.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-3086.99111.00Buy
2022-04-2186.67113.00Buy
2022-07-2763.4691.00Buy
2022-10-2439.0147.00Buy
2023-02-1360.0778.00Buy
2023-05-2468.9095.00Buy
2023-08-0176.78104.00Buy
2023-10-3153.7094.00Buy
2024-02-0889.02137.00Buy
2024-04-30112.29150.00Buy
2024-05-20130.96164.00Buy
2024-07-25149.74180.00Buy
2024-08-14154.00197.00Buy
2024-10-30158.08217.00Buy
2025-04-29138.35230.00Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.